Market Overview - The Geriatric Care Devices Market was valued at USD 14.80 billion in 2025 and is projected to reach USD 26.83 billion by 2033, growing at a CAGR of 7.74% from 2026 to 2033 [1][16]. Growth Drivers - The growth of the geriatric care devices market is primarily driven by the rapidly aging global population, rising life expectancy, and increasing prevalence of age-related chronic conditions such as mobility impairments, hearing loss, cardiovascular diseases, and cognitive disorders [2]. - The shift toward home-based care and assisted living facilities is further supporting demand, as healthcare systems seek cost-effective alternatives to long-term hospital stays [4]. U.S. Market Analysis - The U.S. geriatric care devices market was valued at USD 3.82 billion in 2025 and is projected to reach USD 6.75 billion by 2033, expanding at a CAGR of 7.42% [5]. - Growth in the U.S. is supported by a rapidly expanding elderly population, well-established home healthcare infrastructure, and early adoption of technologically advanced care solutions [6]. Product Segmentation - Mobility Aids captured the largest market share of 32.45% in 2025, driven by the growing elderly population and increasing incidence of mobility-limiting conditions [8]. - Monitoring Devices are projected to grow at the fastest CAGR of 9.12%, supported by rising adoption of wearable health trackers and remote monitoring technologies [8]. Application Segmentation - Fall Prevention & Mobility accounted for the highest application share of 34.20% in 2025, primarily due to the high incidence of fall-related injuries among the elderly [9]. - Elderly Monitoring is expected to expand at the fastest CAGR of 9.05%, driven by the rising need for real-time health monitoring and chronic disease management [9]. End-User Segmentation - Hospitals & Clinics held the largest end-user share of 37.50% in 2025, supported by higher patient inflow and advanced diagnostic infrastructure [10]. - Home Care Settings are anticipated to grow at the fastest CAGR of 8.90%, driven by the shift toward home-based care models [10]. Distribution Channel Analysis - Direct Sales dominated the distribution landscape with a market share of 42.30% in 2025, as hospitals and institutional buyers prefer direct procurement [11]. - Online Platforms are projected to grow at the fastest CAGR of 9.25%, fueled by increasing digital adoption and wider product availability [11]. Regional Insights - North America contributed to more than 35.25% of the global geriatric care devices market revenue in 2025, with significant installations of mobility aids and monitoring devices [12]. - The Asia Pacific geriatric care devices market is estimated to register a CAGR of 8.84%, driven by increasing integration of smart and IoT-enabled solutions [13]. Major Players - Key players in the geriatric care devices market include Cardinal Health, Invacare Corporation, Medline Industries, and Sonova Holding AG among others [14].

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $697 million, up from just under $687 million in Q3 2024, with a year-to-date revenue of nearly $2.1 billion, reflecting a 3.4% increase [14][15][18] - Adjusted EBITDA for Q3 2025 was $92 million, down from $108 million in Q3 2024, impacted by a one-time revenue benefit from the previous year [16][18] - Adjusted net income per share was $0.25 for Q3 2025, compared to $0.36 in Q3 2024, while year-to-date adjusted net income per share increased to $0.80 from $0.64 [18] Business Line Data and Key Metrics Changes - Year-over-year growth was noted in sleep therapy, ostomy, and urology categories, while diabetes showed flat performance compared to Q3 2024 but improved from Q2 2025 [15][16] - The company is focusing on improving therapy adherence and expanding customer capture across its ecosystem [15] Market Data and Key Metrics Changes - The company is positioned to benefit from the growing prevalence of chronic conditions such as diabetes and sleep apnea, with over 37 million diagnosed with diabetes and an estimated 85 million adults affected by obstructive sleep apnea in the U.S. [8][9] Company Strategy and Development Direction - The company announced a definitive agreement to sell its Products and Healthcare Services segment to Platinum Equity, allowing it to focus on its Patient Direct business and home-based care [5][6] - Future investments will prioritize technology and automation to enhance patient experience and operational efficiency [9][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the home-based care business and the potential for growth following the divestiture, emphasizing a unified strategic focus [11][22] - The company anticipates a strong 2026, despite a significant customer loss, and plans to manage operational costs and improve cash flow [27][30] Other Important Information - The company expects to incur approximately $40 million in annualized stranded costs from the divestiture [18] - As of September 30, net debt was $2.1 billion, with expectations for slight reduction by year-end [19][20] Q&A Session Summary Question: Durability of trends going into 2026 and selling into the Optum channel - Management indicated that the Optum channel is new and expected to create more opportunities, with guidance for 2026 to be provided closer to year-end [26][27] Question: Outlook for 2026 and free cash flow trends - Management expects decent top-line growth and margin improvement in 2026, with free cash flow trends anticipated to remain stable despite some one-off costs [30][32] Question: Details on preferred provider agreements and filling the Kaiser contract loss - Management noted that it would take less revenue growth to cover the loss of the Kaiser contract due to its low margin nature, and emphasized the importance of preferred provider agreements [37][39] Question: Clarification on cash flow and balance sheet issues - Management explained that cash flow challenges were related to startup costs of a new kitting facility and over-acquired inventory, which are expected to normalize over time [40][42]